QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
NYSE:GPX

GP Strategies (GPX) Stock Price, News & Analysis

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)
Free GPX Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$20.84
▼
$20.86
50-Day Range
$20.63
▼
$20.85
52-Week Range
$9.36
▼
$20.93
Volume
396,192 shs
Average Volume
109,783 shs
Market Capitalization
$365.94 million
P/E Ratio
28.56
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
GPX stock logo

About GP Strategies Stock (NYSE:GPX)

GP Strategies Corp. provides training, e-Learning solutions, management consulting and engineering services. It operates through the following Geographic Segments: North America, EMEA and Emerging Markets (Latin America and Asia Pacific countries). It provides Workforce Transformation Services into three primary solution sets: Organizational Performance Solutions (OPS), Technical Performance Solutions (TPS) and Automotive Performance Solutions (APS). The company was founded in 1959 and is headquartered in Columbia, MD.

GPX Stock News Headlines

April 9, 2024 | msn.com
Stella defends McLaren F1 team strategy in “complex” Japanese GP
April 5, 2024 | msn.com
Japanese GP data: What we learned from practice at Suzuka
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
March 28, 2024 | investopedia.com
Bootstrapping Definition, Strategies, and Pros/Cons
March 23, 2024 | businessinsider.com
Free F1 live stream: Where to watch every Formula 1 GP race weekend from anywhere
March 17, 2024 | msn.com
Honda MotoGP development not being focused on Marquez helping everyone - Zarco
January 4, 2024 | finance.yahoo.com
Ambient Scientific's Edge AI Processor goes into volume production
January 3, 2024 | finance.yahoo.com
GP Strategies Joins Forces with Quantum5 to Transform Automotive Retail Industry Support
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
December 27, 2023 | msn.com
GPX Unveils Limited Japan-Only GTM250R Cafe Racer
December 13, 2023 | investopedia.com
How Game Theory Strategy Improves Decision-Making
December 11, 2023 | msn.com
GPT-4’s 'secret weapon' is available as open source
November 20, 2023 | msn.com
10 MotoGP Innovations That Changed The Way We Ride
October 28, 2023 | health.usnews.com
Strategies for Avoiding Holiday Weight Gain
October 21, 2023 | investing.com
GPX Historical Data
September 2, 2023 | thestreet.com
GP Strategies Corporation News
August 30, 2023 | seekingalpha.com
Plains GP Holdings: Healthy Financials Coupled With Upside Growth Potentials
July 30, 2023 | mirror.co.uk
Best and worst of Britain's GP surgeries - find out how your practice stacks up
July 18, 2023 | finance.yahoo.com
Plywood Global Market Opportunities And Strategies To 2032
May 30, 2023 | bbc.co.uk
Essex GP struck off over 'sexually motivated' examination
April 21, 2023 | msn.com
Athletics-Scottish runner disqualified for 'using vehicle' in ultra-marathon
April 19, 2023 | yahoo.com
Ultramarathon runner explains ‘massive error’ after being disqualified for using a car
April 19, 2023 | msn.com
Scottish ultrarunner disqualified from race - after tracking data gave away her 'unsporting' secret
April 19, 2023 | msn.com
Ultramarathon runner disqualified for using a car - and she still finished third
April 19, 2023 | msn.com
Ultramarathoner rides in car during part of 50-mile race, gets disqualified
April 18, 2023 | msn.com
Ultrarunner disqualified for using a car in race
April 18, 2023 | bbc.co.uk
Top ultrarunner Joasia Zakrzewski disqualified for using a car in race
See More Headlines
Receive GPX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GP Strategies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/08/2021
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Consumer Discretionary
Industry
Educational Services
Sub-Industry
Human Resource & Employment Services
Current Symbol
NYSE:GPX
CUSIP
36225V10
CIK
70415
Web
www.gpstrategies.com
Phone
(443) 367-9600
Fax
N/A
Employees
4,343
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
$0.73
Trailing P/E Ratio
28.56
Forward P/E Ratio
20.05
P/E Growth
1.32
Net Income
$7.07 million
Net Margins
2.73%
Pretax Margin
N/A
Return on Equity
9.09%
Return on Assets
5.38%

Debt

Debt-to-Equity Ratio
0.04
Current Ratio
1.97
Quick Ratio
1.97

Sales & Book Value

Annual Sales
$473.11 million
Price / Sales
0.77
Cash Flow
$1.20 per share
Price / Cash Flow
17.34
Book Value
$13.01 per share
Price / Book
1.60

Miscellaneous

Outstanding Shares
17,551,000
Free Float
N/A
Market Cap
$365.94 million
Optionable
Optionable
Beta
1.64
12 Stocks Corporate Insiders are Abandoning Cover
12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Adam Henry Stedham
    President, Chief Executive Officer & Director
  • Michael R. Dugan
    Chief Financial Officer & Executive Vice President
  • Matt Young
    SVP, Chief Information & Security Officer
  • James L. Galante
    Secretary, Senior Vice President & General Counsel
  • Matt Donovan
    SVP, Chief Learning & Innovation Officer

Key Competitors

View All Competitors

GPX Stock Analysis - Frequently Asked Questions

How were GP Strategies' earnings last quarter?

GP Strategies Co. (NYSE:GPX) released its earnings results on Sunday, August, 8th. The company reported $0.33 EPS for the quarter, topping analysts' consensus estimates of $0.23 by $0.10. The firm earned $128.78 million during the quarter, compared to the consensus estimate of $127.29 million. GP Strategies had a trailing twelve-month return on equity of 9.09% and a net margin of 2.73%.

What is Adam H. Stedham's approval rating as GP Strategies' CEO?

14 employees have rated GP Strategies Chief Executive Officer Adam H. Stedham on Glassdoor.com. Adam H. Stedham has an approval rating of 76% among the company's employees.

What other stocks do shareholders of GP Strategies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GP Strategies investors own include Bravura Solutions (BVS), Northstar Realty Europe (NRE), Maxar Technologies (MAXR), AT&T (T), Verizon Communications (VZ), General Motors (GM), Alphabet (GOOG), Pfizer (PFE), Exxon Mobil (XOM) and AbbVie (ABBV).

This page (NYSE:GPX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media